Clinical Trial Update: Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose spironolactone versus placebo in acute heart failure has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: Duke University | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2017-05-17